November 3, 2015 : DCMS #265

DISASTERS AVERTED — Near Miss Case Studies

With Injection Techniques, Seeing is Teaching

HOMERUN SLIDES — Great Clinical Presentation Highlights

The Present and Future of Insulin Therapy Part 14

SPECIAL FEATURE

Ingenuities, Advancements, and Future Endeavors  in the Treatment of Diabetes

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dr. Larry Hirsch, Part 1: Efficacy of the Nano Needle in Obese Patients

MOST POPULAR ARTICLES OF THE MONTH

#1  Bacterial Link Between Heart Disease and Gum Disease Clarified
#2 Artificial Pancreas for Type 1 Diabetes
#3 FDA Approves New Long-Acting Insulin: Tresiba and Ryzodeg

Each week we try to bring you the latest in diabetes care, and some of you often email me about the Homerun Slides and how they often explore therapies with drugs that are not available to use in practice. This week’s Slides look at studies using a yet-to-be-approved GLP-1 analog with insulin. Our goal is to provide you with the latest ideas in therapy and let you decide if it is a class effect or limited to the compound in the slides.

In order to move past the latest classes of drugs and see what the future will hold, our PharmD Candidate, Tyler Frisch, reviewed the current research in medications and put together Ingenuities, Advancements, and Future Endeavors in the Treatment of Diabetes. This well-written overview will give you great insight into what the near future holds for diabetes care.

Announcements

Reminder — the Drug Lookup tool is now live again on our website! You can access it here or from anywhere on DiabetesInControl.com — just look for it on the right side of each page. Search by brand name, scientific name, or drug class.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

I asked a patient with erratic glucose levels where he usually gave his insulin injections to which he responded, “In my arms.” I asked, “Could you show me where?” The patient promptly rolled up his sleeves and pointed to the vein in his antecubital space.

In this week’s Homerun Slides, the effectiveness of Lixisenatide when added to basal insulin, and strategies for avoiding or minimizing the GI effects of GLP-1.

Researchers approximate that 387 million people worldwide are living with diabetes mellitus, whose prevalence will reach 10% of the world’s adult population (592 million) by 2035.

Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.

A bacterial species common to both diseases increases arterial inflammation by altering gene expression.

Closed-loop system at home over 12 weeks feasible in type 1 patients.

FDA approved new long-acting insulin degludec for treatments of diabetes mellitus.